People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, ...
A new pill called baxdrostat is showing strong results in lowering dangerously high blood pressure in people who don’t respond to standard treatments. In a large global trial, patients saw their blood ...
A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.
AI predicted that a forgotten breast cancer drug could be repurposed to treat many respiratory and gastrointestinal viruses, ...
People who take this pill don't have to adhere to rules like taking it first thing in the morning or on an empty stomach.
A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved ...
In fact, one of the big fears among people taking GLP-1 agonists (the class of drug to which Ozempic belongs) is that they’ll ...
In an ambitious study, memory and learning abilities improved substantially after exercise among mice with a form of the ...
Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they ...
The weight-loss drugs that took the world by storm a few years ago have a drawback for anyone afraid of needles: they must be injected weekly. But scientists have been racing to perfect anti-obesity ...
Atrogi AB is making a bid for a slice of the obesity market and has dosed the first overweight subjects with ATR-258, an oral therapy it says mimics the effects of exercise, driving loss of fat whilst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results